Prosensa

A company developing RNA-based therapeutics for genetic disorders, infections and cancer

Overview Structured Data Issues Contributors

prosensa.eu

Is a

Company

Organization

Company attributes

Industry

RNA-based and RNA-targeted therapeutics

Location

AngelList URL

CIK Number

Investors

NEA (New Enterprise Associates)

IRS Number

954,805,655

Founded Date

January 1, 2002

Total Funding Amount (USD)

55,072,800

Latest Funding Round Date

January 25, 2012

Stock Symbol

RNA

Exchange

Nasdaq

Latest Funding Type

Series B

Patents Assigned (Count)

Wellfound ID

prosensa

Country

Netherlands

Headquarters

Leiden

Other attributes

Company Operating Status

Active

SIC Code

2,834

Wikidata ID

Q7250583

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Prosensa

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.